These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 12182433

  • 1. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial doppler ultrasonographic velocities, and cerebral artery diameters.
    Oskouian RJ, Martin NA, Lee JH, Glenn TC, Guthrie D, Gonzalez NR, Afari A, Viñuela F.
    Neurosurgery; 2002 Jul; 51(1):30-41; discussion 41-3. PubMed ID: 12182433
    [Abstract] [Full Text] [Related]

  • 2. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage.
    Elliott JP, Newell DW, Lam DJ, Eskridge JM, Douville CM, Le Roux PD, Lewis DH, Mayberg MR, Grady MS, Winn HR.
    J Neurosurg; 1998 Feb; 88(2):277-84. PubMed ID: 9452236
    [Abstract] [Full Text] [Related]

  • 3. Endovascular therapy for aneurysmal vasospasm.
    Newell DW, Elliott JP, Eskridge JM, Winn HR.
    Crit Care Clin; 1999 Oct; 15(4):685-99, v. PubMed ID: 10569116
    [Abstract] [Full Text] [Related]

  • 4. Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm.
    Murayama Y, Song JK, Uda K, Gobin YP, Duckwiler GR, Tateshima S, Patel AB, Martin NA, Viñuela F.
    AJNR Am J Neuroradiol; 2003 Jan; 24(1):133-9. PubMed ID: 12533342
    [Abstract] [Full Text] [Related]

  • 5. Effect of intraarterial papaverine and/or angioplasty on the cerebral veins in patients with vasospasm after subarachnoid hemorrhage due to ruptured intracranial aneurysms.
    Elsayed AA, Moran CJ, Cross DT, Derdeyn CP, Pilgram TK, Milburn JM, Dacey RG, Diringer MN.
    Neurosurg Focus; 2006 Sep 15; 21(3):E16. PubMed ID: 17029340
    [Abstract] [Full Text] [Related]

  • 6. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm.
    Vajkoczy P, Horn P, Bauhuf C, Munch E, Hubner U, Ing D, Thome C, Poeckler-Schoeninger C, Roth H, Schmiedek P.
    Stroke; 2001 Feb 15; 32(2):498-505. PubMed ID: 11157189
    [Abstract] [Full Text] [Related]

  • 7. Coadjuvant Treatment of Vasospasm in Ruptured Unsecured Cerebral Aneurysms with Aggressive Angioplasty, Intra-Arterial Nimodipine, and Aneurysm Embolization.
    Chen CC, Yi-Chou Wang A, Chen CT, Hsieh PC.
    World Neurosurg; 2018 Aug 15; 116():e452-e459. PubMed ID: 29753899
    [Abstract] [Full Text] [Related]

  • 8. The effect of endovascular therapy for cerebral arterial spasm, its limitation and pitfalls.
    Terada T, Kinoshita Y, Yokote H, Tsuura M, Nakai K, Itakura T, Hyotani G, Kuriyama T, Naka Y, Kido T.
    Acta Neurochir (Wien); 1997 Aug 15; 139(3):227-34. PubMed ID: 9143589
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated transcranial Doppler ultrasound velocities following therapeutic arterial dilation.
    Giller CA, Purdy P, Giller A, Batjer HH, Kopitnik T.
    Stroke; 1995 Jan 15; 26(1):123-7. PubMed ID: 7839381
    [Abstract] [Full Text] [Related]

  • 11. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution.
    Suarez JI, Qureshi AI, Yahia AB, Parekh PD, Tamargo RJ, Williams MA, Ulatowski JA, Hanley DF, Razumovsky AY.
    Crit Care Med; 2002 Jun 15; 30(6):1348-55. PubMed ID: 12072693
    [Abstract] [Full Text] [Related]

  • 12. Predictors of outcome after endovascular treatment of cerebral vasospasm.
    Rabinstein AA, Friedman JA, Nichols DA, Pichelmann MA, McClelland RL, Manno EM, Atkinson JL, Wijdicks EF.
    AJNR Am J Neuroradiol; 2004 Jun 15; 25(10):1778-82. PubMed ID: 15569745
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Gonzalez NR, Boscardin WJ, Glenn T, Vinuela F, Martin NA.
    J Neurosurg; 2007 Dec 15; 107(6):1101-12. PubMed ID: 18077946
    [Abstract] [Full Text] [Related]

  • 17. The relationship of blood velocity as measured by transcranial doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage.
    Clyde BL, Resnick DK, Yonas H, Smith HA, Kaufmann AM.
    Neurosurgery; 1996 May 15; 38(5):896-904; discussion 904-5. PubMed ID: 8727814
    [Abstract] [Full Text] [Related]

  • 18. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm.
    Mathis JM, Jensen ME, Dion JE.
    Neuroradiology; 1997 Feb 15; 39(2):90-8. PubMed ID: 9045968
    [Abstract] [Full Text] [Related]

  • 19. Effect of age on cerebral blood flow velocity and incidence of vasospasm after aneurysmal subarachnoid hemorrhage.
    Torbey MT, Hauser TK, Bhardwaj A, Williams MA, Ulatowski JA, Mirski MA, Razumovsky AY.
    Stroke; 2001 Sep 15; 32(9):2005-11. PubMed ID: 11546889
    [Abstract] [Full Text] [Related]

  • 20. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage.
    Liu JK, Couldwell WT.
    Neurocrit Care; 2005 Sep 15; 2(2):124-32. PubMed ID: 16159054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.